Clinical Trial Update: Phase II/III Study of the Safety and Effectiveness of HRIG With Active Rabies Vaccine in Healthy Subjects [Phase 2, Phase 3]

View source ↗

Summary

Phase II/III trial assessing the safety and effectiveness of HRIG with active rabies vaccine in healthy subjects has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rabies

Drugs mentioned

• HRIG with Active Rabies Vaccine (human rabies immunoglobulin with active rabies vaccine)

Snippet

Sponsor: Kamada, Ltd. | Conditions: Rabies | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2021-09-29